𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Model for End-stage Liver Disease

✍ Scribed by Singal, Ashwani K.; Kamath, Patrick S.


Book ID
120467180
Publisher
Elsevier
Year
2013
Tongue
English
Weight
309 KB
Volume
3
Category
Article
ISSN
0973-6883

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Model for end-stage liver disease
✍ G.E. Jung; J. Encke; J. Schmidt; A. Rahmel πŸ“‚ Article πŸ“… 2008 πŸ› Springer 🌐 German βš– 432 KB
The model for end-stage liver disease (M
✍ Patrick S. Kamath; W. Ray Kim πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 153 KB πŸ‘ 1 views

The Model for End-stage Liver Disease (MELD) was initially created to predict survival in patients with complications of portal hypertension undergoing elective placement of transjugular intrahepatic portosystemic shunts. The MELD which uses only objective variables was validated subsequently as an

Clinically relevant differences in the M
✍ Rhiana Garritsen; Andrei Tintu; Herold Metselaar; Geert Kazemier πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 38 KB πŸ‘ 1 views

With interest, we read the article by Xiol et al. 1 regarding differences in serum measurements between different laboratories and their influence on the Model for End-Stage Liver Disease (MELD) and the Model for End-Stage Liver Disease incorporating serum sodium (MELD-Na). They reported significant

Reply: Clinically relevant differences i
✍ Xavier Xiol; Jose Castellote; Xavier Fuentes-Arderiu πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 37 KB πŸ‘ 1 views

We thank Garritsen et al. 1 for their interest in our article about differences in Model for End-Stage Liver Disease (MELD) and Model for End-Stage Liver Disease-Sodium (MELD-Na) scores determined at 3 different laboratories. 2 We agree that one of the important messages of our article is the import